BIOSENSOR CORP

BIOSENSOR CORP focuses on designing and selling electromechanical monitoring and therapy devices used primarily in hospitals, surgical centers, and research clinics that demand the precision and regulatory compliance of the Electromedical & Electrotherapeutic Apparatus sector (SIC 3841) within the broader healthcare technology economy. Its core offerings span biosensors, patient monitoring arrays, and specialized electrode systems that create an integrated platform for clinicians overseeing critical care and neuromuscular rehabilitation, serving a base of healthcare providers, OEM partners, and institutional buyers who prize data integrity, safety certifications, and aftermarket service. The business navigates material risks tied to FDA oversight, reimbursement shifts, supply-chain disruptions, and the scientific validation required before deploying devices into patient care, noting that its most recent disclosure was a Form 8-K filed in January 1999; despite the limited public activity, the balance of product innovation and compliance vigilance remains pivotal. CIK 708282 underscores the firm’s registration history, so view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025